US Edition
CircERC1 Facilitates Chemoresistance through Inhibiting Pyroptosis and Remodeling Extracellular Matrix in Pancreatic Cancer
Summary by Stemwell Science News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
CircERC1 Facilitates Chemoresistance through Inhibiting Pyroptosis and Remodeling Extracellular Matrix in Pancreatic Cancer
Scientists revealed a novel circERC1 as a key regulator in pancreatic ductal adenocarcinoma-secreted EVs following paclitaxel treatment, thereby inhibiting gemcitabine/Nab-paclitaxel induced pyroptosis. [Molecular Cancer] Full Article
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium